SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10069	Companies
205847	Keywords
136110	Articles
109148	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 03/28/2025 at 07:00, 11 months 26 days ago

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for COPD patients based on pivotal phase 3 results in adults with elevated eosinophils, marking a new treatment approach for COPD

Japan COPD Dupixent Phase 3 Results Biologic Medicine
PRESS RELEASE

published on 03/28/2025 at 07:00, 11 months 26 days ago

Communiqué de presse : Le Dupixent devient le tout premier biomédicament approuvé au Japon pour le traitement de la BPCO
Le Dupixent est le premier biomédicament approuvé au Japon pour traiter la BPCO, avec des résultats positifs provenant d'études de phase III. Paris, New York - 28 mars 2025

Japon BPCO Dupixent Étude De Phase III Biomédicament
PRESS RELEASE

published on 03/24/2025 at 19:27, 11 months 30 days ago

Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE

published on 03/24/2025 at 19:27, 11 months 30 days ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 03/24/2025 at 07:35, 11 months 30 days ago

Mise en ligne du document « Q1 2025 Aide mémoire » par Sanofi

Résultats Financiers Investisseurs Sanofi Aide Mémoire Q1 2025
BRIEF

published on 03/24/2025 at 07:35, 11 months 30 days ago

Sanofi launches the “Q1 2025 Aide mémoire” document

Financial Results Investors Sanofi Q1 2025 Memory Aid
PRESS RELEASE

published on 03/24/2025 at 07:30, 11 months 30 days ago

Communiqué de presse : Mise en ligne du document « Q1 2025 Aide mémoire »
Annonce de la mise en ligne du document 'Q1 2025 Aide mémoire' par Sanofi sur l'espace Investisseurs du site internet. Résultats du premier trimestre 2025 à venir le 24 avril 2025

Annonce Résultats Trimestriels Sanofi Q1 2025 Document En Ligne
PRESS RELEASE

published on 03/24/2025 at 07:30, 11 months 30 days ago

Press Release: Availability of the Q1 2025 Aide mémoire
Sanofi announced the availability of the Q1 2025 Aide mémoire on its website to assist in financial modeling, including non-comparable items and first quarter reminders

Sanofi Financial Modeling Aide Mémoire Q1 2025 Exclusivity Losses
PRESS RELEASE

published on 03/10/2025 at 21:09, 1 year ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 03/10/2025 at 21:09, 1 year ago

Sanofi : Déclaration des transactions sur actions propres

Accesswire

Published on 03/23/2026 at 22:40, 1 hour 27 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 1 hour 37 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 2 hours 7 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 2 hours 49 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 10 hours 2 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 22:05, 2 hours 2 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 3 hours 2 minutes ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 3 hours 2 minutes ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 3 hours 7 minutes ago

Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 3 hours 12 minutes ago

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Les Echos

Published on 03/23/2026 at 19:08, 4 hours 59 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 4 hours 59 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 5 hours 30 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 6 hours 22 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 6 hours 22 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE